About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
High Blood Pressure and Cardiovascular Prevention
›
Top Articles
High Blood Pressure and Cardiovascular Prevention
2.9
(top 6%)
Impact Factor
3.4
(top 6%)
extended IF
27
(top 14%)
H-Index
523
authors
1K
papers
4K
citations
990
citing journals
3.9K
citing authors
Most Cited Articles of High Blood Pressure and Cardiovascular Prevention
Title
Year
Citations
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms
2013
93
Middle and Long-Term Impact of a Very Low-Carbohydrate Ketogenic Diet on Cardiometabolic Factors: A Multi-Center, Cross-Sectional, Clinical Study
2015
81
Telemedicine and M-Health in Hypertension Management: Technologies, Applications and Clinical Evidence
2016
71
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome
2016
54
Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation
2016
50
Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours
2008
49
2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy
2013
47
Endothelial Dysfunction in Obesity: Role of Inflammation
2016
44
Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues
2015
43
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project
2020
42
Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
2017
40
The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging
2018
39
How to assess microvascular structure in humans
2011
35
Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document
2019
34
Vascular Aging and Disease of the Large Vessels: Role of Inflammation
2019
34
The importance of autophagy in cardioprotection
2014
33
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension
2020
32
Cushing's Syndrome: Screening and Diagnosis
2016
32
Pathophysiological Links Among Hypertension and Alzheimer's Disease
2016
30
Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses
2015
30
Tolerability of Nebivolol in Head-To-Head Clinical Trials Versus Other Cardioselective β-Blockers in the Treatment of Hypertension
2005
30
Vascular Aging and Disease of the Small Vessels
2019
28
Hypertension in Young People: Epidemiology, Diagnostic Assessment and Therapeutic Approach
2015
28
Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease
2014
28
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial
2015
27
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.